chr2-86117158-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_017952.6(PTCD3):c.413C>T(p.Pro138Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000132 in 1,074,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_017952.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152014Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000156 AC: 38AN: 243184Hom.: 0 AF XY: 0.0000986 AC XY: 13AN XY: 131780
GnomAD4 exome AF: 0.0000803 AC: 74AN: 921976Hom.: 0 Cov.: 13 AF XY: 0.0000645 AC XY: 31AN XY: 480922
GnomAD4 genome AF: 0.000447 AC: 68AN: 152132Hom.: 0 Cov.: 33 AF XY: 0.000390 AC XY: 29AN XY: 74374
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2023 | The c.413C>T (p.P138L) alteration is located in exon 6 (coding exon 6) of the PTCD3 gene. This alteration results from a C to T substitution at nucleotide position 413, causing the proline (P) at amino acid position 138 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at